TY - JOUR
T1 - Regulation of organic anion transporters
T2 - Role in physiology, pathophysiology, and drug elimination
AU - Zhang, Jinghui
AU - Wang, Haoxun
AU - Fan, Yunzhou
AU - Yu, Zhou
AU - You, Guofeng
N1 - Funding Information:
This work was supported by grants (to Dr. Guofeng You) from National Institute of General Medical Sciences ( R01-GM079123 , R01-GM097000 and R01-GM127788 ).
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2021/1
Y1 - 2021/1
N2 - The members of the organic anion transporter (OAT) family are mainly expressed in kidney, liver, placenta, intestine, and brain. These transporters play important roles in the disposition of clinical drugs, pesticides, signaling molecules, heavy metal conjugates, components of phytomedicines, and toxins, and therefore critical for maintaining systemic homeostasis. Alterations in the expression and function of OATs contribute to the intra- and inter-individual variability of the therapeutic efficacy and the toxicity of many drugs, and to many pathophysiological conditions. Consequently, the activity of these transporters must be highly regulated to carry out their normal functions. This review will present an update on the recent advance in understanding the cellular and molecular mechanisms underlying the regulation of renal OATs, emphasizing on the post-translational modification (PTM), the crosstalk among these PTMs, and the remote sensing and signaling network of OATs. Such knowledge will provide significant insights into the roles of these transporters in health and disease.
AB - The members of the organic anion transporter (OAT) family are mainly expressed in kidney, liver, placenta, intestine, and brain. These transporters play important roles in the disposition of clinical drugs, pesticides, signaling molecules, heavy metal conjugates, components of phytomedicines, and toxins, and therefore critical for maintaining systemic homeostasis. Alterations in the expression and function of OATs contribute to the intra- and inter-individual variability of the therapeutic efficacy and the toxicity of many drugs, and to many pathophysiological conditions. Consequently, the activity of these transporters must be highly regulated to carry out their normal functions. This review will present an update on the recent advance in understanding the cellular and molecular mechanisms underlying the regulation of renal OATs, emphasizing on the post-translational modification (PTM), the crosstalk among these PTMs, and the remote sensing and signaling network of OATs. Such knowledge will provide significant insights into the roles of these transporters in health and disease.
KW - Drug disposition
KW - Drug transporter
KW - Organic anion transporter
KW - Post-translational modification
KW - Regulation
UR - http://www.scopus.com/inward/record.url?scp=85089357182&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089357182&partnerID=8YFLogxK
U2 - 10.1016/j.pharmthera.2020.107647
DO - 10.1016/j.pharmthera.2020.107647
M3 - Review article
C2 - 32758646
AN - SCOPUS:85089357182
SN - 0163-7258
VL - 217
JO - Pharmacology and Therapeutics, Part A: Chemotherapy, Toxicology and
JF - Pharmacology and Therapeutics, Part A: Chemotherapy, Toxicology and
M1 - 107647
ER -